Abstract Submissions Closed

ABSTRACT SUBMISSIONS ARE NOW CLOSED

Welcome to the APAM 2025 Abstract Submission page! We are opening late breaking abstracts for posters and flash posters only in the Open Theme. 

The 118th Annual Meeting of AoPGBI, happening on April 3-4, 2025, is your opportunity to share groundbreaking research with clinicians and researchers from across the globe.

Our thoughtfully curated themes will explore the convergence of technological innovation, precision medicine, and the ethical challenges that define modern clinical practice. These topics aim to foster rigorous academic inquiry, inspire interdisciplinary collaboration, and stimulate the exchange of groundbreaking insights.

Key Themes for APAM 2025 Abstract Submission

The Association warmly welcomes a wide range of themes under its ‘Open Theme’ category, and this is the Symposium which will launch APAM 2025, providing a show-case on the quality and breadth of translational research. Please also indicate if your Abstract would be suitable for consideration in one of our Themed sessions when we will address areas that are shaping current and future health challenges and solutions.

The Symposium will address where molecules and machines enmesh to offer health systems opportunities. We will launch this theme with a plenary presentation on insights from multi-omics and machine learning into maladaptive responses in infections including COVID-19, both acutely and in survivors. We welcome all Abstracts utilising any variety of ‘Omics, other big data or AI with a goal to improve.

Understanding health impacts from the rapidly changing environment of the modern world offers opportunities for disease prevention. This Symposium invites Abstracts on triggers such as pollution, climate change, diet, drugs, digital, infection, sedentary and toxic states, unknown to Osler, where the challenge links to a medically-focused potential solution.

The last few years have seen breakthroughs in conceptual and technical delivery of therapeutics, now able to address previously undruggable diseases. The Symposium invites Abstracts that address the new opportunities in this area, enabled by advances in understanding biology, new technologies and inter-disciplinary approaches.

Timeline information for your Medical Research Abstracts

November
Abstract Submission Now Open
Researchers preparing for APAM 2025 Abstract Submission

Abstracts must be submitted online, where you will be guided through the process. Any abstract submitted on paper or in a format other than specified will be rejected. Submitted abstracts should include unpublished data.

20th January 2025
Abstract Submission Will Close
Researchers preparing for APAM 2025 Abstract Submission

All abstracts will be anonymously reviewed and scored for originality, quality of data, presentation and significance.

Mid February
Acceptance Notifications Issued
Notifications of Abstract Acceptance
Researchers preparing for APAM 2025 Abstract Submission

Confirmation of abstract acceptance will be issued. All accepted abstract presenters will be required to register for the Meeting by a given date in early 2025 at the appropriate rate. Please note, that whilst AoP membership is not required for abstract submission, it is encouraged.

Abstract Submissions Closed

ORAL SCIENTIFIC PRESENTATIONS

Presenters will be allocated a maximum of 10 minutes for their presentation including time for questions. PowerPoint presentation facilities will be provided for speakers. 

THE OSLER PRIZE

The highest ranked abstracts will be accepted for oral presentations and be considered for the “Osler Prize” awarded by the AoP. The top oral presenter (Osler awardee) at the Meeting in London 2025, will be awarded a travel fellowship to present their poster at the American Society for Clinical Investigation (ASCI) Conference in Chicago in 2026. Only AoP members are eligible for the oral prize. If you are not a member, there is still time to apply for membership. See here for further information

POSTER PRESENTATIONS

High quality abstracts that are not selected for oral presentation may be accepted for poster presentation. An award will be made for the best poster presentation. Only AoP members are eligible for the poster prizes. If you are not a member, there is still time to apply for membership. See here for further information

REGISTRATION OF ABSTRACT PRESENTERS

All accepted abstract presenters will be required to register for the Meeting by a given date in February 2025 at the appropriate rate. Please note, that whilst AoP membership is not required for abstract submission, it is encouraged.

TRAVEL BURSARIES FOR AOP MEMBER (NON CONSULTANT GRADE) ABSTRACT PRESENTERS

A limited number of bursaries (up to £200 towards travel/accommodation) are available for AoP Emerging Clinical Researcher Member non consultant abstract presenters who take an active role in the Meeting Programme. Please express your interest at the time of abstract submission – Not a member? join today

Dr Emily Watts APAM 2025

Dr Emily Watts

Wellcome Trust Clinical Research Career Development Fellow, University of Edinburgh

I am a respiratory physician and Wellcome Trust Clinical Research Career development fellow based in Edinburgh. My research interests are in understanding the molecular mechanisms which underpin neutrophilic inflammatory lung disease. Using air pollution as a model of inflammation my fellowship is focused on how neutrophils sense and respond to inflammatory and metabolic cues in the environment and how this drives neutrophil synthetic and inflammatory capacity.

Professor Sir Doug Turnbull

Emeritus Professor of Neurology Newcastle University

Sir Doug Turnbull is Emeritus Professor of Neurology, Newcastle University (UK). Professor Turnbull was Director of the Wellcome Centre for Mitochondrial Research and Director of the MRC Centre for Ageing and Vitality. He was the clinical lead for the NHS Highly Specialised Service for Rare Mitochondrial Diseases of Adults and Children.

Professor Turnbull’s research focused on understanding the role of mitochondria in health and disease. This has led to a new understanding of the importance and complexity of mitochondrial DNA disease, the development of a novel method to prevent the transmission of mitochondrial DNA disease (mitochondrial donation).

Mala Maini

Professor Mala Maini

Professor of Viral Immunology, University College London

Mala Maini is a Professor of Viral Immunology in the Institute of Immunity and Transplantation, Division of Infection and Immunity at UCL, London and an Honorary Consultant Physician in the viral hepatitis clinic. Her lab studies adaptive immunity to hepatitis B, liver cancer and SARS-CoV-2 to inform the development of immunotherapies and vaccines for these major causes of morbidity and mortality. Through access to well-characterised patient cohorts, human tissue samples and models, their studies provide insights into beneficial and dysfunctional T and B cell responses. The lab is particularly interested in dissecting and harnessing tissue-resident immunity for frontline sentinel surveillance of viruses and cancer.  Mala enjoys mentoring and supporting her lab members to obtain fellowships and develop their careers. Work in the Maini lab is funded by Wellcome (including Mala’s Investigator Award), UKRI, Cancer Research UK, ERC Horizon 2020 and the Royal Free Charity.
 

Professor Helen McShane

Professor of Vaccinology, University of Oxford

Helen McShane FRCP, PhD, FMedSci is Director, NIHR Oxford Biomedical Research Centre; Professor of Vaccinology, University of Oxford; Deputy Head, Medical Sciences Division and an Honorary Consultant Physician in Infectious Diseases.
Since 2001, Helen has lead the TB vaccine research group at the University of Oxford, and has expertise in vaccine design through to phase IIb efficacy testing. She led the development of the first candidate TB vaccine to enter efficacy testing, and now works on alternate routes of delivery and the development of controlled human infection models for TB and SARS CoV2.

Prof. Sarah Walmsley

AoPGBI Executive Committee Member and Professor of Respiratory Medicine at the University of Edinburgh

I am a Professor of Respiratory Medicine, University of Edinburgh, Honorary Consultant Physician, NHS Lothian and Co-Director of the Edinburgh Clinical Academic Training Scheme.  I undertook my medical training at the University of Edinburgh graduating in 1997, and an MRC training fellowship at the University of Cambridge with award of my PhD in 2004.  My specialist training in Respiratory Medicine was in Sheffield, where I also held a Welcome Intermediate Fellowship, prior to my move to Edinburgh as a Welcome Senior Clinical Fellow.  During this time, I had two periods of maternity leave.  I am currently based in the Centre for Inflammation Research in the Institute for Regeneration and Repair in Edinburgh.  My work is focused on understanding how local oxygen and nutrient availability in the inflamed environment can reprogram neutrophil behaviour in both acute and chronic inflammatory lung disease states.

APAM 2025

Dr Shera Chok

GP, NHS
Founder and Chair, The Shuri Network
NED, London Ambulance Service NHS Trust
National Lead for Community Settings, NIHR

Shera Chok is a GP in the NHS and is the former Chief Medical Officer at NHS Digital. She is an experienced national clinical leader who has worked at Board and Director levels since 2000 and has led the redesign and implementation of new models of care, digital innovation, clinical governance, workforce and leadership development at national and local levels.
She started the award-winning national Shuri Network in 2019 as she is passionate about increasing diversity, innovation and safety and to encourage other women from minority ethnic groups to lead and engage with digital transformation.
She has been recognised as an AI Visionary by the Kent, Surrey and Sussex Health Innovation Network & Department of Health and Social Care in 2025 and won the Zenith Global Health Special Recognition Award in 2023. She was awarded the prestigious Richard von Weizsäcker Fellowship by the Robert Bosch Foundation in 2023 and won the HSJ Race Equality Award winner in 2021 with the Shuri Network.
She advised ministers as a member of the NHS Independent Reconfiguration Panel for seven years and worked at Barts Health, the largest acute hospital trust in the NHS as Director of Primary Care for six years, helping to improve patient pathways across organisational boundaries.
Shera has volunteered as a clinician in countries including Sudan, Laos, Indonesia and Greece with NGOs working in war and disaster zones and with displaced populations. She studied at the Institute of Healthcare Improvement, Kennedy School of Government and the Harvard School of Public Health on an NHS executive leadership programme. She has completed an M.B.A., M.A. in Inter-professional Education and a Nuffield Trust Fellowship on cross-organisational learning with Sunderland Athletic Football Club.

Helen Devine APAM 2025

Dr Helen Devine

Newcastle University, Clinical NUAcT Fellow and Honorary
Consultant Neurologist

Dr Helens Bio coming soon

Professor Patrick Chinnery

Executive Chair of the Medical Research Council

Patrick Chinnery is Professor of Neurology at the University of Cambridge and an Honorary Consultant Neurologist at Addenbrooke’s Hospital. He runs a combined clinical and laboratory research programme based in the MRC Mitochondrial Biology Unit and has been supported by Wellcome since 1995 including a Principal Research Fellowship. He is known for his expertise in rare inherited diseases that affect the nervous system. His lab has been studying the genetic basis of mitochondrial disorders for over two decades, harnessing the power of whole genome sequencing and developing new treatments through experimental medicine and early phase trials. He jointly chairs the NIHR BioResource for Translational Research in Common and Rare diseases, is Executive Chair of the UK Medical Research Council and life sciences lead for UK Research and Innovation.